Back
Checkpoint Therapeutics Quote, Financials, Valuation and Earnings
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
36
CKPT
Checkpoint Therapeutics
Last Price:
3.46
Seasonality Move:
2.96%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Checkpoint Therapeutics Price Quote
$3.46
+0.26 (+8.13%)
(Updated: November 12, 2024 at 5:55 PM ET)
Checkpoint Therapeutics Key Stats
Sell
36
Checkpoint Therapeutics (CKPT)
is a Sell
Day range:
$3.09 - $3.47
52-week range:
$1.36 - $3.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
940.4K
Avg. volume:
943.7K
1-year change:
79.78%
Market cap:
$144.1M
Revenue:
$103K
EPS:
$-1.9
How Much Does Checkpoint Therapeutics Make?
Data Unavailable
Is Checkpoint Therapeutics Growing As A Company?
-
What Is Checkpoint Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.32% -
What Is Checkpoint Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Checkpoint Therapeutics Stock Price Performance
-
Did Checkpoint Therapeutics Stock Go Up Last Month?
Checkpoint Therapeutics share price went up by 31.42% last month -
Did CKPT's Share Price Rise Over The Last Year?
CKPT share price rose by 79.78% over the past 1 year
What Is Checkpoint Therapeutics 52-Week High & Low?
-
What Is Checkpoint Therapeutics’s 52-Week High Share Price?
Checkpoint Therapeutics has traded as high as $3.97 over the past 52 weeks -
What Is Checkpoint Therapeutics’s 52-Week Low Share Price?
Checkpoint Therapeutics has traded as low as $1.36 over the past 52 weeks
Checkpoint Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Checkpoint Therapeutics?
-
How Much Debt Does Checkpoint Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Checkpoint Therapeutics Have?
Cash and short term investments quarterly total is $5M -
What Is Checkpoint Therapeutics’s Book Value Per Share?
Book value per share is -0.37
Is Checkpoint Therapeutics Cash Flow Positive?
-
What Is CKPT Cash Flow From Operations?
Cash flow from operations (TTM) is -$34.3M -
What Is Checkpoint Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $31.8M -
What Is Checkpoint Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Checkpoint Therapeutics Return On Invested Capital
Data Unavailable
Checkpoint Therapeutics Earnings Date & Stock Price
-
What Is Checkpoint Therapeutics's Stock Price Today?
A single share of CKPT can be purchased today for 3.20 -
What Is Checkpoint Therapeutics’s Stock Symbol?
Checkpoint Therapeutics trades on the nasdaq under the ticker symbol: CKPT -
When Is Checkpoint Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Checkpoint Therapeutics is scheduled on November 13, 2024 -
When Is CKPT's next ex-dividend date?
Checkpoint Therapeutics's next ex-dividend date is November 13, 2024 -
How To Buy Checkpoint Therapeutics Stock?
You can buy Checkpoint Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Checkpoint Therapeutics Competitors
-
Who Are Checkpoint Therapeutics's Competitors?
Below is a list of companies who compete with Checkpoint Therapeutics or are related in some way:
Checkpoint Therapeutics Dividend Yield
-
What Is CKPT Dividend Yield?
Checkpoint Therapeutics’s dividend yield currently is 0% -
What Is Checkpoint Therapeutics’s Payout Ratio?
Checkpoint Therapeutics’s payout ratio is 0% -
When Did Checkpoint Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 13, 2024 -
What Is Checkpoint Therapeutics’s Dividend Per Share?
Checkpoint Therapeutics pays a dividend of $0.00 per share
Checkpoint Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 32.26% | 296.9% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 17.00 |
| Upside from Last Price: | 431.25% |